Substance abuse and psychiatric dual disorders: Focus on tobacco

Journal of Dual Diagnosis

Volumn 1, Issue 1, 2004, Pages 15-36

  Gold, Mark S ^a,b   Frost Pineda, Kimberly ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Alcohol; Dual disorders; Eating disorders; Environmental tobacco smoke; ETS; Second hand smoke; SHS; Smoking; sUDs; Tobacco

Indexed keywords

COTININE; NICOTINE;

ALCOHOLISM; CIGARETTE SMOKING; DEPRESSION; DIFFERENTIAL DIAGNOSIS; EATING DISORDER; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MENTAL DISEASE; MORBIDITY; MORTALITY; PASSIVE SMOKING; POSITRON EMISSION TOMOGRAPHY; PRENATAL EXPOSURE; PREVALENCE; PUBLIC HEALTH; REVIEW; SCHIZOPHRENIA; SMOKING; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; UNITED STATES;

EID: 24144461196     PISSN: 15504263     EISSN: None     Source Type: Journal    
DOI: 10.1300/J374v01n01_03     Document Type: Review

References (101)

1. Davis, R.M., Moving tobacco control beyond "the tipping point." BMJ, 2000. 321(7257): p. 309-10.
2. Gurkan, F., et al., The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis. Eur J Epidemiol, 2000. 16(5): p. 465-8.
3. Willes, S.R., et al., Acute respiratory response to prolonged, moderate levels of sidestream tobacco smoke. J Toxicol Environ Health A, 1998. 53(3): p. 193-209.
4. Witschi, H., J.P. Joad, and K.E. Pinkerton, The toxicology of environmental tobacco smoke. Annu Rev Pharmacol Toxicol, 1997. 37: p. 29-52.
5. Villablanca, A.C., J.M. McDonald, and J.C. Rutledge, Smoking and cardiovascular disease. Clin Chest Med, 2000. 21(1): p. 159-72.
6. Otsuka R, Watanabe H, Hirata K, Tokai K, Muro T, Yoshiyama M, Takeuchi K, Yoshikawa J. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA. 2001 Jul 25;286(4):436-41.
7. Targeting Tobacco Use: The Nation's Leading Cause of Death. 2003, U.S. Department of Health and Human Services. Centers for Disease Control and Prevention: Atlanta.
8. Witschi, H., Tobacco toxicology revisited. Adv Exp Med Biol, 2001. 500: p. 471-8.
9. Samet, J.M., Workshop summary: assessing exposure to environmental tobacco smoke in the workplace. Environ Health Perspect, 1999. 107 Suppl 2: p. 309-12.
10. Harlap, S. and P.H. Shiono, Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet, 1980. 2(8187): p. 173-6.
11. Naeye, R.L., Abruptio placentae and placenta previa: frequency, perinatal mortality, and cigarette smoking. Obstet Gynecol, 1980. 55(6): p. 701-4.
12. Naeye, R.L., Factors that predispose to premature rupture of the fetal membranes. Obstet Gynecol, 1982. 60(1): p. 93-8.
13. Cornelius MD, Goldschmidt L, Day NL, Larkby C. Alcohol, tobacco and marijuana use among pregnant teenagers: 6-year follow-up of offspring growth effects. Neurotoxicol Teratol. 2002 Nov-Dec;24(6):703-10.
14. Law KL, Stroud LR, LaGasse LL, Niaura R, Liu J, Lester BM. Smoking during pregnancy and newborn neurobehavior. Pediatrics. 2003 Jun;111(6 Pt 1):1318-23.
15. England LJ, Kendrick JS, Wilson HG, Merritt RK, Gargiullo PM, Zahniser SC. Effects of smoking reduction during pregnancy on the birth weight of term infants. Am J Epidemiol. 2001 Oct 15;154(8):694-701.
16. Kallen, K., The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health., 2001. 11(3): p. 329-33.
17. Toivonen, S., et al., Reproductive risk factors, Doppler findings, and outcome of affected births in placental abruption: a population-based analysis. Am J Perinatol, 2002. 19(8): p. 451-60.
18. Walsh RA, Lowe JB, Hopkins PJ. Quitting smoking in pregnancy. Med J Aust. 2001 Sep 17;175(6):320-3.
19. Kallen, K., The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health., 2001. 11(3): p. 329-33.
20. MacArthur, C. and E.G. Knox, Smoking in pregnancy: effects of stopping at different stages. Br J Obstet Gynaecol, 1988. 95(6): p. 551-5.
21. McLeod D, Pullon S, and Cookson T, Factors that influence changes in smoking behaviour during pregnancy. N Z Med J, 2003. 116(1173): p. U418.
22. Kohler E, Bretschneider D, Rabsilber A, Weise W, Jorch G. Assessment of prenatal smoke exposure by determining nicotine and its metabolites in maternal and neonatal urine. Hum Exp Toxicol. 2001 Jan;20(1):1-7.
23. Abdel-Rahman A, Dechkovskaia AM, Mehta-Simmons H, Sutton JM, Guan X, Khan WA, Abou-Donia MB. Maternal exposure to nicotine and chlorpyrifos, alone and in combination, leads to persistently elevated expression of glial fibrillary acidic protein in the cerebellum of the offspring in late puberty. Arch Toxicol. 2004 Mar 26 [Epub ahead of print].
24. Fowler JS, Logan J, Wang GJ, Volkow ND. Monoamine oxidase and cigarette smoking. Neurotoxicology. 2003 Jan;24(1):75-82.
25. Matt GE, Quintana PJ, Hovell MF, Bernert JT, Song S, Novianti N, Juarez T, Floro J, Gehrman C, Garcia M, Larson S. Households contaminated by environmental tobacco smoke: sources of infant exposures. Tob Control. 2004 Mar;13(1):29-37.
26. Jarvis, M.J., et al., Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. Bmj, 2000. 321(7257): p. 343-5.
27. Ashley, M.J. and R. Ferrence, Reducing children's exposure to environmental tobacco smoke in homes: issues and strategies. Tob Control, 1998. 7(1): p. 61-5.
28. Ferrence, R. and M.J. Ashley, Protecting children from passive smoking. BMJ, 2000. 321(7257): p. 310-1.
29. Milberger S, Biederman J, Faraone SV, Jones J. Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. J Clin Child Psychol. 1998 Oct;27(3):352-8.
30. Environmental tobacco smoke: a hazard to children. American Academy of Pediatrics Committee on Environmental Health. Pediatrics, 1997. 99(4): p. 639-42.
31. Miller, D.P., et al., Birth and first-year costs for mothers and infants attributable to maternal smoking. Nicotine Tob Res, 2001. 3(1): p. 25-35.
32. Chang, M.Y., et al., Salivary cotinine levels in children presenting with wheezing to an emergency department. Pediatr Pulmonol, 2000. 29(4): p. 257-63.
33. Arborelius, E., A.C. Hallberg, and A. Hakansson, How to prevent exposure to tobacco smoke among small children: a literature review. Acta Paediatr Suppl, 2000. 89(434): p. 65-70.
34. Klonoff-Cohen, H.S., et al., The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. Jama, 1995. 273(10): p. 795-8.
35. Tuomi, T., T. Johnsson, and K. Reijula, Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC-tandem mass spectrometry. Clin Chem, 1999. 45(12): p. 2164-72.
36. Al-Delaimy, W.K., J. Crane, and A. Woodward, Passive smoking in children: effect of avoidance strategies, at home as measured by hair nicotine levels. Arch Environ Health, 2001. 56(2): p. 117-22.
37. Etter, J.F., T. Vu Due, and T.V. Perneger, Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol, 2000. 151(3): p. 251-8.
38. Hansen, A.M., et al., Reference interval and subject variation in excretion of urinary metabolites of nicotine from non-smoking healthy subjects in Denmark. Clin Chim Acta, 2001. 304(1-2): p. 125-32.
39. Nafstad, P., et al., Comparison of three methods for estimating environmental tobacco smoke exposure among children aged between 12 and 36 months. Int J Epidemiol, 1995. 24(1): p. 88-94.
40. Brunekreef, B., et al., Using nicotine measurements and parental reports to assess indoor air: the PIAMA birth cohort study. Prevention and Incidence of Asthma and Mite Allergy. Epidemiology, 2000. 11(3): p. 350-2.
41. Clark, S.J., J.O. Warner, and T.P. Dean, Passive smoking amongst asthmatic children. Questionnaire or objective assessment? Clin Exp Allergy, 1994. 24(3):p. 276-80.
42. Goldberger BA, Melker RJ, Merves ML, Frost-Pineda K, Gold MS. Measuring and quantifying substance exposure: Cotinine in exhaled breath. Society for Neuroscience 2004.
43. Kessler, R., Nelson, C., McGonagle, K. The Epidemiology of Co-occurring Addictive and Mental Disorders: Implications for Prevention and Service Utilization. American Journal of Orthopsychiatry 1996; 66: 17-31.
44. Kessler, McGonagle, Zhao, et al. Lifetime and 12-month Prevalence of DSM-III-R Psychiatric Disorders in the United States. Arch Gen Psychiatry 1994; 51:8-19.
45. Kessler, R. The Epidemiology of Co-occurring Addictive and Mental Disorders. NCS Working Paper #9. Invited conference paper, presented at the SAMHSA sponsored conference; Improving Services for Individuals with Co-occurring Substance Abuse and Mental Health Disorders 11/13/95.
46. Wagner FA, Anthony JC. Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am J Epidemiol. 2002 May 15;155(10):918-25.
47. Ciraulo, D.A., Shader, R.I., Clinical manual of chemical dependence 1991; American Psychiatric Press; 204-209.
48. Schuckit MA: Alcoholism and affective disorder: diagnostic confusion: In Goodwin DW and Erikson CK (Eds): Alcoholism and Affective Disorders. New York: SP Medical and Scientific Books, 1979, pp 9-19.
49. Solomon J (1989). Alcoholism and psychiatric disorders. In HW Goedde & PD Agarwal (Eds.) Alcoholism: Biomedical and Genetic Aspects. New York, N.Y. Pergamon Press pages 216-27.
50. Schuckit, MA., Tipp, JE., Bergman, M., Reich, W., Hesselbrock, VM., Smith, TL. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry 1997; 154:948-957.
51. Reiger, DA., Myers, JK., Kramer, M., Robins, LN., Blazer, DG., Hough, RI., Eaton, WW., Locked, BZ. 1984. The NIMH epidemiologic catchment area program. Archives of General Psychiatry 41:934-941.
52. Rose JE, Behm FM, Westman EC, Mathew RJ, London ED, Hawk TC, Turkington TG, Coleman RE. PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry. 2003 Feb;160(2):323-33.
53. Due DL, Huettel SA, Hall WG, Rubin DC. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry. 2002 Jun;159(6):954-60.
54. Laviolette SR, van der Kooy D. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry. 2003 Jan;8(1):50-9, 9.
55. Obot IS, Wagner FA, Anthony JC. Early onset and recent drug use among children of parents with alcohol problems: data from a national epidemiologic survey. Drug Alcohol Depend. 2001 Dec 1;65(1):1-8.
56. Patten, C.A.; Martin, J.E.; and Owen, N. Can psychiatric and chemical dependency treatment units be smoke free? J Subst Abuse Treat 13(2):107-118, 1996.
57. Hurt, R.D.; Offord, K.P.; Croghan, I.T.; et al. Mortality following inpatient addictions treatment: Role of tobacco use in a community-based cohort. JAMA 275(14):1097-1103, 1996.
58. Blot, WJ. Alcohol and cancer. Cancer Res (supp.) 52:2119s-2123s, 1992.
59. Hughes J. Do smokers with current or past alcoholism need different or more intensive treatment? Alcohol Clin Exp Res. 2002 Dec;26(12):1934-5.
60. Novy P, Hughes JR, Callas P. A comparison of recovering alcoholic and non-alcoholic smokers. Drug Alcohol Depend. 2001 Dec 1;65(1): 17-23.
61. Schaefer GJ, Michael RP. Interactions between alcohol and nicotine on intracranial self-stimulation and locomotor activity in rats. Drug Alcohol Depend. 1992 Apr;30(1):37-47.
62. Rose JE, Brauer LH, Behm FM, Cramblett M, Calkins K, Lawhon D. Potentiation of nicotine reward by alcohol. Alcohol Clin Exp Res. 2002 Dec;26(12):1930-1.
63. Blomqvist O, Ericson M, Johnson DH, Engel JA, Soderpalm B. Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. Eur J Pharmacol. 1996 Oct 31;314(3):257-67.
64. Blomqvist O, Ericson M, Engel JA, Soderpalm B. Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine. Eur J Pharmacol. 1997 Sep 10;334(2-3):149-56.
65. Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science. 2004 Mar 5;303(5663): 1512-4.
66. Corrigall WA, Coen KM, Adamson KL. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 1994 Aug 8;653(1-2):278-84.
67. Sziraki I, Sershen H, Hashim A, Lajtha A. Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem Res. 2002 Mar;27(3):253-61.
68. Larsson A, Engel JA. Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev. 2004 Jan;27(8):713-20.
69. Aistrup GL, Marszalec W, Narahashi T. Ethanol modulation of nicotinic acetylcholine receptor currents in cultured cortical neurons. Mol Pharmacol. 1999 Jan; 55(1):39-49.
70. U.S. Department of Health and Human Services (USDHHS). The Health Consequences of Smoking: Cancer, a Report of the Surgeon General. DHHS (PHS) No. 82-50179. Washington, DC: Supt. of Docs., U.S. Govt. Print. Off., 1982.
71. Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, Sidransky D. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res 2000 Jun 15;60(12):3155-9.
72. Weber A, Tannapfel A, Wittekind C, Bootz F. Carcinogen-induced site-specific mutagenesis and genetic susceptibility in squamous cell carcinoma of the head and neck. Onkologie 2002 Feb;25(1):8-13.
73. Castellsagué X, Muñoz N, De Estefani E et al., Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. International Journal of Cancer 82 (1999), pp. 654-657.
74. Zambon P, Talamini R, La Vecchia C, et al., Smoking, type of alcoholic beverage and squamous-cell oesophageal cancer in northern Italy. International Journal of Cancer 86 (2000), pp. 144-149.
75. Cawley MJ; Guse TM; Laroia A; Haith LR; Ackerman BH. Propofol withdrawal syndrome in an adult patient with thermal injury. Pharmacotherapy 23(7): 933-939, 2003.
76. Farrell M; Howes S; Bebbington P; Brugha T; Jenkins R; Lewis G et al. Nicotine, alcohol and drug dependence, and psychiatric comorbidity-results of a national household survey (Reprinted from British Journal of Psychiatry 179, pgs 432-437, 2001). International Review of Psychiatry 15(1-2): 50-56, 2003.
77. Farrell M; Howes S; Taylor C; Lewis G; Jenkins R; Bebbington P et al. Substance misuse and psychiatric comorbidity: an overview of the OPCS National Psychiatric Morbidity Survey (Reprinted from Addictive Behaviours 23, pgs 909-918, 1998). International Review of Psychiatry 15(1-2): 43-49, 2003.
78. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001 Jun 16;357(9272): 1929-32.
79. Laje RP, Berman JA, Glassman AH. Depression and nicotine: preclinical and clinical evidence for common mechanisms. Curr Psychiatry Rep. 2001 Dec;3(6):470-4.
80. Epping-Jordan MP, Watkins SS, Koob GF, Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 1998 May 7;393(6680):76-9.
81. Kenny PJ, Markou A. Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav. 2001 Dec;70(4):531-49.
82. Gamberino WC, Gold MS. Neurobiology of tobacco smoking and other addictive disorders. Psychiatr Clin North Am. 1999 Jun;22(2):301-12.
83. Rigotti NA. Clinical practice. Treatment of tobacco use and dependence. N Engl J Med. 2002 Feb 14;346(7):506-12.
84. Gold MS, Frost-Pineda K. Eating disorders, overeating and pathological attachment to food: Independent or addictive disorders. J Addict Dis 2004; 23(3):1-4.
85. Gold MS, Frost-Pineda K, Jacobs, WS. Overeating, Binge Eating, and Eating Disorders as Addictions. Psych Annals. 2003; 33:2, 117-122.
86. Kleiner KD, Gold MS, Frost-Pineda K, Lenz-Brunsman B, Perri MG, Jacobs WS. Body Mass Index and Alcohol Use. J Addict Dis 2004; 23(3):105-118.
87. Hodgkins CC, Cahill KS, Seraphine AE, Frost-Pineda K, Gold MS. Adolescent Drug Addiction Treatment and Weight Gain. J Addict Dis 2004; 23(3):55-66.
88. Cabanac M, Frankham P. Evidence that transient nicotine lowers the body weight set point. Physiol Behav. 2002 Aug;76(4-5):539-42.
89. J.A. Bushnell, J.E. Wells, J.M. McKenzie, A.R. Hornblow, M.A. Oakley-Browne and P.R. Joyce, Bulimia comorbidity in the general population and in the clinic. Psychological Medicine 24 (1994), pp. 605-611.
90. Wiederman MW and Pryor T. Substance use and impulsive behaviors among adolescents with eating disorders. Addictive Behaviors 21 (1996), pp. 269-272.
91. Bulik CM, Sullivan PF, Kendler KS. Medical and psychiatric morbidity in obese women with and without binge eating. Int J Eat Disord. 2002 Jul;32(1):72-8.
92. Taylor AV, Peveler RC, Hibbert GA, Fairburn CG. Eating disorders among women receiving treatment for an alcohol problem. Int J Eating Disord. 1993; 14:147-151;
93. Peveler RC, Fairburn CG. Eating disorders in women who abuse alcohol. Br J Addict. 1990; 85:1633-1638.
94. Hudson JI, Weiss RD, Pope HG Jr, McElroy SK, Mirin SM. Eating disorders in hospitalized substance abusers. Am J Drug Alcohol Abuse. 1992;18(1):75-85.
95. Grilo CM, Levy KN, Becker DF, Edell WS, McGlashan TH. Eating disorders in female inpatients with versus without substance use disorders. Addict Behav. 1995 Mar-Apr;20(2):255-60.
96. Schuckit MA, Tipp JE, Anthenelli RM, Bucholz KK, Hesselbrock VM, Nurnberger JI Jr. Anorexia nervosa and bulimia nervosa in alcohol-dependent men and women and their relatives. Am J Psychiatry. 1996 Jan;153(1):74-82.
97. Krahn DD. The relationship of eating disorders and substance abuse. J Subst Abuse. 1991; 3:239-253.
98. Newman MM, Gold MS. Preliminary findings of patterns of substance abuse in eating disorders patients. Am J Drug Alcohol Abuse. 1992; 18:207-211.
99. Beary MD, Lacey JH, Merry J. Alcoholism and eating disorders in women of fertile age. Br J Addict. 1986; 81:685-689.
100. Filstead WJ, Parrella DP, Ebbit J. High-risk situations for engaging in substance abuse and binge-eating behaviors. J Stud Alcohol. 1987; 49:136-140.
101. Kaye WH, Lilenfeld LR, Plotnicov K, Merikangas KR, Nagy L, Strober M, Bulik CM, Moss H, Greeno CG. Bulimia nervosa and substance dependence: association and family transmission. Alcohol Clin Exp Res. 1996 Aug;20(5):878-81.